Zelboraf

Zelboraf

Marketed minn: Roche Registration GmbH
Ingredjent attiv: vemurafenib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Xeloda

Xeloda

Marketed minn: Roche Registration GmbH
Ingredjent attiv: capecitabine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Trydonis

Trydonis

Marketed minn: Chiesi Farmaceutici S.p.A.
Ingredjent attiv: beclometasone dipropionate / formoterol fumarate dihydrate / glycopyrronium

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Truxima

Truxima

Marketed minn: Celltrion Healthcare Hungary Kft.
Ingredjent attiv: rituximab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Truvada

Truvada

Marketed minn: Gilead Sciences International Limited
Ingredjent attiv: emtricitabine / tenofovir disoproxil fumarate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Tobi Podhaler

Tobi Podhaler

Marketed minn: Novartis Europharm Limited
Ingredjent attiv: tobramycin

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Tecentriq

Tecentriq

Marketed minn: Roche Registration GmbH
Ingredjent attiv: atezolizumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Tasermity

Tasermity

Marketed minn: Genzyme Europe BV
Ingredjent attiv: sevelamer hydrochloride

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Steglujan

Steglujan

Marketed minn: Merck Sharp & Dohme Limited
Ingredjent attiv: ertugliflozin l-pyroglutamic-aċidu / sitagliptin phosphate monohydrate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Steglatro

Steglatro

Marketed minn: Merck Sharp & Dohme Limited
Ingredjent attiv: ertugliflozin l-pyroglutamic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Segluromet

Segluromet

Marketed minn: Merck Sharp & Dohme Limited
Ingredjent attiv: ertugliflozin l-pyroglutamic-aċidu / metformin hydrochloride

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ristempa

Ristempa

Marketed minn: Amgen Europe B.V.
Ingredjent attiv: pegfilgrastim

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)

Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)

Marketed minn: Chiesi Farmaceutici S.p.A.
Ingredjent attiv: beclometasone dipropionate anhydrous / formoterol fumarate dihydrate / glycopyrronium

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Relvar Ellipta

Relvar Ellipta

Marketed minn: Glaxo Group Ltd
Ingredjent attiv: fluticasone furoate / vilanterol

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Raxone

Raxone

Marketed minn: Santhera Pharmaceuticals (Deutschland) GmbH
Ingredjent attiv: idebenone

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)

Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)

Marketed minn: EUSA Pharma (UK) Limited
Ingredjent attiv: dinutuximab beta

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

ProQuad

ProQuad

Marketed minn: MSD VACCINS
Ingredjent attiv: virus, ħaj attenwat, ħosba, virus, ħaj attenwat, gattone, virus, ħaj attenwat, rubella, virus, ħaj attenwat, varikella

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Procoralan

Procoralan

Marketed minn: Les Laboratoires Servier
Ingredjent attiv: ivabradine hydrochloride

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Pritor

Pritor

Marketed minn: Bayer AG
Ingredjent attiv: telmisartan

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Perjeta

Perjeta

Marketed minn: Roche Registration GmbH
Ingredjent attiv: pertuzumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Pegasys

Pegasys

Marketed minn: Roche Registration GmbH
Ingredjent attiv: peginterferon alfa-2a

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Oprymea

Oprymea

Marketed minn: Krka, d.d., Novo mesto
Ingredjent attiv: pramipexole dihydrochloride monohydrate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Onbrez Breezhaler

Onbrez Breezhaler

Marketed minn: Novartis Europharm Limited
Ingredjent attiv: indacaterol maleate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ocrevus

Ocrevus

Marketed minn: Roche Registration GmbH
Ingredjent attiv: ocrelizumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Nuwiq

Nuwiq

Marketed minn: Octapharma AB
Ingredjent attiv: simoctocog alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

NeoRecormon

NeoRecormon

Marketed minn: Roche Registration GmbH
Ingredjent attiv: epoetin beta

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Mylotarg

Mylotarg

Marketed minn: Pfizer Limited
Ingredjent attiv: gemtuzumab ozogamicin

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Lokelma

Lokelma

Marketed minn: AstraZeneca AB
Ingredjent attiv: sodium żirkonju cyclosilicate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Latuda

Latuda

Marketed minn: Aziende Chimiche Riunite Angelini Francesco S.p.A.
Ingredjent attiv: lurasidone

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Lamzede

Lamzede

Marketed minn: Chiesi Farmaceutici S.p.A.
Ingredjent attiv: velmanase alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Lacosamide Accord

Lacosamide Accord

Marketed minn: Accord Healthcare Ltd
Ingredjent attiv: lacosamide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)

Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)

Marketed minn: Bayer AG
Ingredjent attiv: telmisartan

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency